feed,title,long_url,short_url
Benzinga,"[Latest] Global Hemophilia B Gene Therapy Market Size/Share Worth USD 5,938.5 Billion by 2032 at a 34.1% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)",https://benzinga.com/pressreleases/23/09/g34958988/latest-global-hemophilia-b-gene-therapy-market-sizeshare-worth-usd-5-938-5-billion-by-2032-at-a-34,
